Are you Dr. Srour?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 33 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6620 Main St
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-798-2619- Is this information wrong?
Summary
- Dr. Samer Srour, MD is a hematologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Oklahoma. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2006 - 2009
- Beirut Arab University Faculty of MedicineClass of 2003
Certifications & Licensure
- FL State Medical License 2021 - Present
- TX State Medical License 2015 - 2025
- OK State Medical License 2008 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.Sumanta K Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, Lihua E Budde, Simon J Harrison, Sebastian Klobuch, Sagar S Patel, Luis M...> ;Cancer Discovery. 2024 Apr 5
- Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies.Supawee Saengboon, Julianne Chen, Gabriela Rondon, Jim S Im, Elizabeth J Shpall, Stefan O Ciurea, Uday R Popat, Jeremy Leon Ramdial, Qaiser Bashir, Amin Majid Alousi, ...> ;Blood Advances. 2024 Mar 23
- Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantation.Curtis Marcoux, Rima M Saliba, Whitney Wallis, Sajad Khazal, Dristhi Ragoonanan, Gabriela Rondon, Priti Tewari, Uday Popat, Betul Oran, Amanda Olson, Qaiser Bashir, Mu...> ;Blood Advances. 2024 Mar 12
- Join now to see all
Press Mentions
- Allogene Therapeutics Presents Interim Phase 1 Data on ALLO-316 in Renal Cell Carcinoma at the American Association of Cancer Research (AACR) Annual MeetingApril 17th, 2023
- Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-316 at the American Association of Cancer Research (AACR) Annual MeetingMarch 15th, 2023
- Updated Invectys and CTMC Announce FDA Clearance of IND Application for Anti-HLA-G CAR-T Cell TherapyDecember 20th, 2022
- Join now to see all
Hospital Affiliations
- Oklahoma City VA Medical CenterOklahoma City, Oklahoma
- University of Texas M.D. Anderson Cancer CenterHouston, Texas